May 14, 2020
Dear Advocates,
A new episode of AVAC’s
Px Pulse podcast is ready for download! We take a comprehensive look at the intersection of HIV and COVID-19.
In this episode,
Mark Feinberg, CEO of
IAVI, lays out the innovations developed to advance an HIV vaccine that are now being leveraged to accelerate COVID-19 vaccine development at unprecedented speeds.
Helen Rees, Executive Director of the
Wits Reproductive Health and HIV Institute (Wits RHI), pulls back the curtain on preparations started years ago by the Coalition for Epidemic Preparedness Innovation (
CEPI) to develop and deliver vaccines for “disease X”, which now turns out to be COVID-19.
Sinead Delany-Moretlwe, Director of Research at Wits RHI, Vincent Basajja of the
Uganda Virus Research Institute,
Jau Nanyondo from
Uganda’s Makerere University Walter Reed Project and Philister Adhiambo from the
Kenya Medical Research Institute explain challenges faced by HIV prevention trials and innovative efforts to adapt site by site, in the wake of COVID-19.
For more on research in this new era, check out resources, webinar recordings and more on AVAC’s special
COVID-19 and HIV page.
For the full podcast episode, highlights and more resources, visit
avac.org/px-pulse. And subscribe on
Apple Podcasts,
Spotify or wherever you get your podcasts!
Best,
AVAC
